279 related articles for article (PubMed ID: 25728286)
1. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.
Litvinov IV; Tetzlaff MT; Rahme E; Habel Y; Risser DR; Gangar P; Jennings MA; Pehr K; Prieto VG; Sasseville D; Duvic M
Cancer; 2015 Jun; 121(12):1993-2003. PubMed ID: 25728286
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
3. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.
Litvinov IV; Tetzlaff MT; Rahme E; Jennings MA; Risser DR; Gangar P; Netchiporouk E; Moreau L; Prieto VG; Sasseville D; Duvic M
Cancer Med; 2015 Sep; 4(9):1440-7. PubMed ID: 26136403
[TBL] [Abstract][Full Text] [Related]
4. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.
Moreau JF; Buchanich JM; Geskin JZ; Akilov OE; Geskin LJ
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046454
[TBL] [Abstract][Full Text] [Related]
5. Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.
Clough L; Bayakly AR; Ward KC; Khan MK; Chen SC; Lechowicz MJ; Flowers CR; Allen PB; Switchenko JM
Cancer; 2020 Apr; 126(8):1700-1707. PubMed ID: 31943154
[TBL] [Abstract][Full Text] [Related]
6. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
7. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Roshdy O; Pehr K; Sasseville D; Litvinov IV
J Cutan Med Surg; 2018; 22(2):154-165. PubMed ID: 29241349
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
Criscione VD; Weinstock MA
Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
[TBL] [Abstract][Full Text] [Related]
10. Association of airborne toxins with geographic clustering of cutaneous T-cell lymphoma in Louisiana.
Maghfour J; Gill F; Olson J; Guido N; Echuri H; Murina A
J Am Acad Dermatol; 2022 Nov; 87(5):1184-1186. PubMed ID: 35271939
[No Abstract] [Full Text] [Related]
11. Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories.
Henry KA; Wiese D; Maiti A; Harris G; Vucetic S; Stroup AM
Cancer Causes Control; 2021 Sep; 32(9):989-999. PubMed ID: 34117957
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
13. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
15. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
16. Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.
Litvinov IV; Shtreis A; Kobayashi K; Glassman S; Tsang M; Woetmann A; Sasseville D; Ødum N; Duvic M
Oncoimmunology; 2016 Jul; 5(7):e1175799. PubMed ID: 27622024
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary manifestations in patients with cutaneous T-cell lymphomas.
Baser S; Onn A; Lin E; Morice RC; Duvic M
Cancer; 2007 Apr; 109(8):1550-5. PubMed ID: 17351938
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data.
Assaf C; Dobos G; Zech IM; Doess A; May M; Jadasz J
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1320-1327. PubMed ID: 37845021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
